The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD.

The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD.

Item
http://www.wikidata.org/entity/Q33596821
Combination bronchodilator therapy in the management of chronic obstructive pulmonary diseaseAnticholinergic bronchodilators in combination.Airway wall thickness is increased in COPD patients with bronchodilator responsiveness.Improving the differential diagnosis of chronic obstructive pulmonary disease in primary care.Management of acute exacerbations of chronic obstructive pulmonary disease.Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD.Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPDPharmacological approaches to stable chronic obstructive pulmonary disease.Comparison of the variability of the annual rates of change in FEV₁ determined from serial measurements of the pre- versus post-bronchodilator FEV₁ over 5 years in mild to moderate COPD: results of the lung health study.The use of plethysmography and oscillometry to compare long-acting bronchodilators in patients with COPD.Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studiesCombination of formoterol and tiotropium in the treatment of COPD: effects on lung function.Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.Dual bronchodilator therapy with aclidinium bromide/formoterol fumarate for chronic obstructive pulmonary disease.A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructiThe Prevalence of Chronic Obstructive Pulmonary Disease among Danes Aged 45–84 Years: Population-based Study
P2860

The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD.

Item
http://www.wikidata.org/entity/Q33596821
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The combination of ipratropium ...... testing in patients with COPD.
@ast
The combination of ipratropium ...... testing in patients with COPD.
@en
type
label
The combination of ipratropium ...... testing in patients with COPD.
@ast
The combination of ipratropium ...... testing in patients with COPD.
@en
prefLabel
The combination of ipratropium ...... testing in patients with COPD.
@ast
The combination of ipratropium ...... testing in patients with COPD.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
The combination of ipratropium ...... testing in patients with COPD.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921